시장보고서
상품코드
1603420

세계의 유착 방지제 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 제형별, 지역별 - 산업 예측(2024-2031년)

Adhesion Barrier Market Size, Share, Growth Analysis, By Product (Synthetic, Natural), By Application (Gynecological Surgeries, Cardiovascular Surgeries), By Formulation (Film, Liquid) By Region - Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 유착 방지제 시장 규모는 2022년에 6억 4,000만 달러로 평가되었습니다. 2023년 6억 8,000만 달러에서 2031년까지는 11억 5,000만 달러로 성장하고, 예측 기간(2024-2031년) CAGR은 0.68%를 나타낼 전망입니다.

세계 유착 방지제 시장은 수술 건수 증가, 스포츠 관련 부상 증가, 세계 의료비 지출 증가로 인해 크게 성장할 것으로 예상됩니다. 외과 수술의 급격한 증가를 반영하여 유착 방지제에 대한 수요는 정형외과 및 심장 수술에서 특히 높습니다. 미국에서는 사이클링이나 레크리에이션 스포츠와 같은 활동으로 인해 상당한 부상을 입기 때문에 외과적 솔루션에 대한 필요성이 더욱 커지고 있습니다. 신흥국의 급속한 의료 발전은 인구 증가와 가처분 소득 증가와 함께 시장 확장을 촉진할 것으로 예상됩니다. 그러나 이 시장은 높은 수술 비용, 유착 방지제의 잠재적 부작용, 기술 혁신과 광범위한 채택을 방해하는 엄격한 규제 프레임워크와 같은 문제에 직면해 있습니다.

목차

서론

  • 조사 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 전제조건과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porter's Five Forces 분석과 영향
    • 경쟁 기업간 경쟁 관계
    • 대체품의 위협
    • 바이어의 교섭력
    • 신규 진출업체의 위협
    • 공급 기업의 교섭력

주요 시장 인사이트

  • 주요 성공 요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 기술 진보
  • 규제 상황
  • 특허 분석
  • 밸류체인 분석
  • 사례 연구 분석
  • 고객과 구매 기준 분석
    • PESTEL 분석
  • 시장의 매력 지수
  • 가격 분석

세계의 유착 방지제 시장 규모 : 제품별·CAGR(2024년-2031년)

  • 시장 개요
  • 합성 유착 방지제
    • 히알루론산
    • 재생 셀룰로오스
    • 폴리에틸렌 글리콜
    • 기타
  • 천연 유착 방지제
    • 콜라겐
    • 피브린

세계의 유착 방지제 시장 규모 : 용도별·CAGR(2024년-2031년)

  • 시장 개요
  • 일반외과/복부외과
  • 부인과 수술
  • 심장혈관 수술
  • 정형외과 수술
  • 신경외과
  • 기타

세계의 유착 방지제 시장 규모 : 제제별·CAGR(2024년-2031년)

  • 시장 개요
  • 액체

세계의 유착 방지제 시장 규모·CAGR(2024년-2031년)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 스페인
    • 프랑스
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채택한 전략
  • 시장 최근 동향
  • 기업의 시장 점유율 분석(2023년)
  • 주요 기업 개요
    • 기업 개요
    • 제품 포트폴리오 분석
    • 기업 부문별 점유율 분석
    • 전년대비 매출 비교(2021-2023년)

주요 기업 개요

  • Baxter International Inc.(United States)
  • Anika Therapeutics, Inc.(United States)
  • Sanofi SA(France)
  • Medtronic plc(Ireland)
  • Integra LifeSciences Corporation(United States)
  • Atrium Medical Corporation(Getinge AB)(United States)
  • FzioMed, Inc.(United States)
  • MAST Biosurgery AG(Switzerland)
  • Terumo Corporation(Japan)
  • Johnson & Johnson(United States)
  • Becton, Dickinson and Company(United States)
  • B. Braun Melsungen AG(Germany)
  • Ferring Pharmaceuticals(Switzerland)
  • Adhesion Barrier Company(United States)
  • Fidia Farmaceutici S.p.A.(Italy)
  • Innocoll Holdings PLC(Ireland)
  • Biom'Up SAS(Zimmer Biomet Holdings, Inc.)(France)
  • Aziyo Biologics, Inc.(United States)

결론과 제안

LSH 24.12.18

Global Adhesion Barrier Market size was valued at USD 0.64 billion in 2022 and is poised to grow from USD 0.68 billion in 2023 to USD 1.15 billion by 2031, growing at a CAGR of 0.68% during the forecast period (2024-2031).

The global Adhesion Barrier Market is poised for significant growth, driven by the rising number of surgeries, increasing sports-related injuries, and growing healthcare expenditure worldwide. The demand for adhesion barriers is particularly high in orthopedic and cardiac procedures, reflecting the surge in surgical interventions. In the United States, activities like cycling and recreational sports result in substantial injuries, further fueling the need for surgical solutions. Rapid healthcare advancements in developing countries, coupled with population growth and increased disposable incomes, are expected to enhance market expansion. However, the market faces challenges, including the high cost of surgical procedures, potential side effects of adhesion barriers, and stringent regulatory frameworks that hinder technological innovation and broader adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Adhesion Barrier market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Adhesion Barrier Market Segmental Analysis

Global Adhesion Barrier Market is segmented by Product, Application, Formulation and region. Based on Product, the market is segmented into Synthetic Adhesion Barriers, (Hyaluronic Acid, Regenerated Cellulose, Polyethylene Glycol, and Other Synthetic Adhesion Barriers) and Natural Adhesion Barriers (Collagen and Fibrin)), Based on Application, the market is segmented into General/Abdominal Surgeries, Gynecological Surgeries, Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, and Others. Based on Formulation, the market is segmented into Film, Liquid, and Gel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Adhesion Barrier Market

The global adhesion barrier market is driven by the rising number of surgical procedures across various domains, including general/abdominal, gynecological, cardiovascular, orthopedic, and neurological surgeries. This growing surgical volume escalates the need for effective adhesion barriers to minimize postoperative complications and adhesion formation. Additionally, heightened awareness among healthcare professionals and patients about the severe consequences of adhesions-such as pain, bowel obstruction, infertility, and organ dysfunction-further boosts demand. Technological advancements in adhesion barrier formulations, including synthetic solutions offering enhanced efficacy, biocompatibility, and extended durability, also play a crucial role in market expansion. These innovations not only improve surgical outcomes but also encourage the adoption of adhesion barriers, solidifying their importance in modern medical practices.

Restraints in the Global Adhesion Barrier Market

A significant restraint for the global adhesion barrier market is the high cost associated with these products, which limits their adoption, particularly in price-sensitive regions. Adhesion barriers, often used in surgical procedures to prevent post-operative adhesions, can significantly increase overall treatment costs, making them less accessible for patients and healthcare facilities with constrained budgets. Additionally, the stringent regulatory approval processes for medical devices in various regions can delay market entry for new adhesion barrier products, further hindering growth. Limited awareness among healthcare professionals and patients regarding the long-term benefits of adhesion barriers also contributes to lower adoption rates, particularly in emerging markets. This creates challenges for manufacturers to achieve widespread penetration and expand their market share globally.

Market Trends of the Global Adhesion Barrier Market

The global Adhesion Barrier Market is witnessing transformative trends driving its growth. A notable development is the rising adoption of bioresorbable adhesion barriers, which naturally degrade and are absorbed by the body, eliminating the need for additional surgical removal. This trend aligns with the growing demand for solutions that minimize complications and enhance patient recovery. Additionally, the market is experiencing a surge in product innovation, with companies investing heavily in research and development. These efforts focus on creating advanced adhesion barrier formulations that offer superior biocompatibility, extended efficacy, and improved usability. Together, these trends underscore the market's dynamic nature and its commitment to delivering cutting-edge solutions to meet the evolving needs of healthcare professionals and patients.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • Case Study Analysis
  • Customer & Buying Criteria Analysis
    • PESTEL Analysis
  • Market Attractiveness Index
  • Pricing Analysis

Global Adhesion Barrier Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Synthetic Adhesion Barriers
    • Hyaluronic Acid
    • Regenerated Cellulose
    • Polyethylene Glycol
    • Other
  • Natural Adhesion Barriers
    • Collagen
    • Fibrin

Global Adhesion Barrier Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • General/Abdominal Surgeries
  • Gynecological Surgeries
  • Cardiovascular Surgeries
  • Orthopedic Surgeries
  • Neurological Surgeries
  • Other

Global Adhesion Barrier Market Size by Formulation & CAGR (2024-2031)

  • Market Overview
  • Film
  • Liquid
  • Gel

Global Adhesion Barrier Market Size & CAGR (2024-2031)

  • North America, (Product, Application, Formulation)
    • US
    • Canada
  • Europe, (Product, Application, Formulation)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product, Application, Formulation)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product, Application, Formulation)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product, Application, Formulation)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Baxter International Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Anika Therapeutics, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Atrium Medical Corporation (Getinge AB) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FzioMed, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MAST Biosurgery AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ferring Pharmaceuticals (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Adhesion Barrier Company (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fidia Farmaceutici S.p.A. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Innocoll Holdings PLC (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biom'Up SAS (Zimmer Biomet Holdings, Inc.) (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aziyo Biologics, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제